Via influencing the let-7i expressions, atorvastatin treatment markedly down-regulates TLR4 signal in CAD patients, possibly contributing to the beneficial effects of atorvastatin on these patients [27]. This evidence concerns the gene TLR4 and coronary artery disorder.